An overview of Italfarmaco in Benelux
We are part of the Italfarmaco Group, a family-owned Italian company currently present in over 90 countries. We benefit from the Group’s global expertise and research & development activities, enabling us to provide innovative solutions for patients living with rare diseases.
Effik Benelux, a subsidiary of Italfarmaco since 2015, acts as the Marketing Authorization Holder in the Benelux for the Group’s medicines in the fields of gynecology, neurology and Duchenne muscular dystrophy.
Therapeutic Areas
Here’s where our expertise brings effectiveness.
Our expertise in developing effective treatments enables us to address complex challenges in key therapeutic areas.
Meet our Leaders
Evolution: how to make treatments more accessible for more patients
Pharmaceutics is a dynamic science, constantly evolving to make every medicine, formula, and application more effective. Our commitment to accessibility drives us to provide significant benefits and enable more people to access targeted and effective treatments. In our four research hubs, we focus on identifying new dosing solutions for approved drugs, repurposing reformulations, and developing APIs to deliver high-quality generic medicines to the market, ensuring that healthcare is more inclusive.
